Search

Your search keyword '"Prokopczuk, Janusz"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Prokopczuk, Janusz" Remove constraint Author: "Prokopczuk, Janusz"
43 results on '"Prokopczuk, Janusz"'

Search Results

1. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial

2. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis

3. Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting

4. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial

5. Comparison of reorganized versus unaltered cardiology departments during the COVID-19 era: a subanalysis of the COV-HF-SIRIO 6 study

6. Longer Hospitalizations and Higher In-Hospital Mortality for Acute Heart Failure during the COVID-19 Pandemic in Larger vs. Smaller Cardiology Departments: Subanalysis of the COV-HF-SIRIO 6 Multicenter Study

7. PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens:Insights from the GLOBAL LEADERS and GLASSY

8. Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial

9. Impact of COVID‐19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV‐HF‐SIRIO 6 study)

10. Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY

11. Ticagrelor Monotherapy Beyond One Month after PCI in ACS or Stable CAD in Elderly Patients Aged Above 75 Years: a Prespecified Analysis of the Randomized GLOBAL LEADERS Trial

12. Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial

13. Comparison of Investigator-Reported and Clinical Event Committee–Adjudicated Outcome Events in GLASSY

14. PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY

15. Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial

18. TCT-41 A Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin-Strut Sirolimus-Eluting Coronary Stent Supraflex: 2-Year Results of the TALENT Trial

19. TCT-642 PARIS Risk Score Stratified Analysis of Clinical Outcomes Among Elderly Patients (Aged > 75 Years) Treated With 23-Month Ticagrelor Monotherapy Following 1-Month DAPT After PCI in the GLOBAL LEADERS Trial

20. Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study

21. LONG-TERM TICAGRELOR MONOTHERAPY IN ELDERLY PATIENTS UNDERGOING PCI IN THE GLOBAL LEADERS STUDY

22. Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial

23. Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

24. PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY

25. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

26. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

27. TCT-608 Comparison of stent design on early outcome in patients undergoing primary percutaneous coronary intervention. Insights from large, multicenter, registry

28. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vsaspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

29. TCT-211 Stenting and Delivery of Paclitaxel via Iopromide-Based Balloon Coating versus Durable Polymeric Matrix for De-Novo Coronary Lesions: Clinical and Angiographic Results from the Prospective Randomized Trial.

30. AS-034 Multivessel and Left Main Coronary Artery Stenting in Comparison with Surgical Revascularization in Patients with Non ST Elevation Acute Coronary Syndrome (The MILESTONE Registry)

33. CRT28: BIVENTRICULAR PACING IN PATIENTS WITH SEVERE HEART FAILURE - IMPORTANCE OF LEFT VENTRICULAR PACING SITE.

35. Impact of COVID-19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV-HF-SIRIO 6 study).

36. PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY.

37. Use of the LocaLisa mapping system during ablation procedures in patients with atrioventricular nodal reentrant tachycardia.

38. Electrophysiologic parameters suggesting significant acute cellular rejection of the transplanted heart.

39. Radiofrequency ablation of typical atrial flutter with the use of electro-anatomical mapping system CARTO.

40. Effectiveness of radiofrequency catheter ablation of right ventricular outflow tract tachycardia using the CARTO system.

41. [Diagnostic difficulties in acute pulmonary embolism diagnosis: ECG changes evolution: a case report].

42. [Permanent junction reciprocating tachycardia--treatment with radiofrequency current ablation].

43. [Atrio-ventricular nodal reentrant tachycardia--concepts evolution on the propagation of the reentrant wave front].

Catalog

Books, media, physical & digital resources